Gap junction protein inhibitor, GAP-134, Purity ≥98%

Cat. No.: X24-08-YM347

Gap junction protein inhibitor, GAP-134, Purity ≥98%

Synonym: 943134-39-2; Danegaptide; ZP1609; GAP134; GAP 134; ZP-1609; ZP 1609; (2S,4R)-1-(2-Aminoacetyl)-4-benzamidopyrrolidine-2-carboxylic acid

  • CAS Number: 943134-39-2
  • Compound CID: 16656685
Product Size
5 mg; 10 mg; 50 mg; 100 mg
Price
Datasheet
MSDS
Properties
Description
GAP-134 is an effective cytoskeleton inhibitor, that has the ability to prevent the pathway of cytoskeletal signaling by inhibiting gap junction protein.
Molecular Weight
291.3
Molecular Formula
C14H17N3O4
Form
Lyophilized powder
Purity
≥98%
Titer
Free from inappropriate visible particulates, foreign matter, discoloration, or other defects
Stability
In its lyophilized form, the chemical remains stable for 36 months.
Quality Level
Research grade
Applications
GAP-134 is a cytoskeletal signaling inhibitor that can be used for its role in modulating gap junction communication.
Storage
Store at -20ºC, and keep desiccated.
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.